Skip to main content
. Author manuscript; available in PMC: 2013 Jun 14.
Published in final edited form as: Med Care. 2010 Apr;48(4):321–326. doi: 10.1097/mlr.0b013e3181ca3ffc

Table 3.

Diagnostic strategies of primary care physicians in a case of diagnosed type 2 diabetes with emerging neuropathy by country

p
country		 Countries
Germany UK US Tukey’s Multiple
Comparisons
Number of questions (means) <.001 3.3 3.8 5.7 US > UK = Germany
Questions about (%)

  • Previous neuropathy

  • Problems with footwear

  • Adherence with diet/nutrition

  • Smoking

 <.001 2 9 25 US > UK = Germany
.183 2 6 9 US = UK = Germany
<.001 25 13 48 US > Germany = UK
.009 9 30 27 UK = US > Germany
Foot examinations (%)

  • Any foot examination

  • Check for ulcers

  • Vibration/monofilament test

  • Foot pulses

 .779 94 92 95 US = UK = Germany
<.001 25 6 48 US > Germany > UK
<.001 72 39 64 Germany = US > UK
.040 53 67 73 US = UK;
UK = Germany;
US > Germany
Testing (%)

  • Fasting glucose/HbA1c

  • Casual glucose a

  • Fasting lipids

  • Casual lipids b

 <.001 19 14 77 US > Germany = UK
.050 13 8 2 Germany = UK;
UK = US;
Germany > US
<.001 0 25 61 US > UK > Germany
.316 14 8 6 Germany = UK = US
a

If the physician ordered a fasting glucose or HbA1c, then casual glucose is coded as “no”.

b

If the physician ordered a fasting lipid test, then casual lipids is coded as “no”.